Kyowa Kirin · UCN-01
P2 Phase 2
Pfizer · Sunitinib
P2 Phase 2
Bristol Myers Squibb · Dasatinib
P2 Phase 2
SynCore Biotechnology · EndoTAG-1
P3+ Phase 3+
Merck KGaA · Cetuximab
P2 Phase 2
Bicalutamide
P3+ Phase 3+
(Active)
Roche · Bevacizumab
P3+ Phase 3+
(Active)
Erlotinib
P2 Phase 2
Novartis · Everolimus
P3+ Phase 3+
(Active)
Sanofi · Iniparib
P3+ Phase 3+
AstraZeneca · Saracatinib
P2 Phase 2
AbbVie · Veliparib
P3+ Phase 3+
(Active)
PharmaMar · Trabectedin
P2 Phase 2
Mayo Clinic · CpG oligodeoxynucleotide
P1 Phase 1
Mayo Clinic · MUC1 peptide vaccine with poly-ICLC
P1 Phase 1
Oxaliplatin
P2 Phase 2
DORMATARG, INC
PC Preclinical
Syndax Pharmaceuticals · Entinostat
P2 Phase 2
Merck & Co. · Dalotuzumab
P1 Phase 1
Bendamustine
P2 Phase 2
Panitumumab
P2 Phase 2
(Active)
Nippon Kayaku · NK012
P2 Phase 2
Oncovir · Poly-ICLC
P2 Phase 2
(Active)
Temsirolimus
P1 Phase 1
Tigris Pharmaceuticals · AFP464
IND IND
NOVOMEDIX, INC
PC Preclinical
Amgen · Ganitumab
P2 Phase 2
Amgen · Trebananib
P2 Phase 2
Athenex · Oral paclitaxel + encequidar
P2 Phase 2
Dostarlimab
P2 Phase 2
(Active)
Metformin
P2 Phase 2
(Active)
Sarilumab
P2 Phase 2
(Active)
TriSalus Life Sciences · SD-101
P2 Phase 2
Vyriad · Voyager-V1
P2 Phase 2
Roche · RO4929097
P2 Phase 2
Vismodegib
P2 Phase 2
pharmaand · Rucaparib
P2 Phase 2
Estradiol
P2 Phase 2
(Active)
Nerviano / Cell Therapeutics · Brostallicin
P2 Phase 2
Panobinostat
P2 Phase 2
AstraZeneca · Cediranib
P2 Phase 2
(Active)
GSK · Uprosertib
P2 Phase 2
Novartis · Trametinib
P2 Phase 2
Barbara Ann Karmanos Cancer Institute · HER2 BATs
P2 Phase 2
Adlai Nortye · Buparlisib
P2 Phase 2
Jiangsu Hengrui Pharmaceuticals · Apatinib
P3+ Phase 3+
(Active)
Roche · Onartuzumab
P2 Phase 2
Decitabine
P2 Phase 2
(Active)
Sorafenib
P2 Phase 2
Lapatinib
P2 Phase 2
(Active)
Azacitidine
P2 Phase 2
(Active)
Daiichi Sankyo · Tigatuzumab
P2 Phase 2
Merck & Co. · MK-2206
P2 Phase 2
Piramal Enterprises · Riviciclib
P1 Phase 1
Cyclacel Pharmaceuticals · Seliciclib
P1 Phase 1
Pfizer · Binimetinib
P2 Phase 2
(Active)
Novartis · LGK974
P1 Phase 1
Novartis · Spartalizumab
P2 Phase 2
(Active)
Merrimack Pharmaceuticals · Seribantumab
P2 Phase 2
Cellectar Biosciences · Iopofosine I-131
P1 Phase 1
(Active)
SIBTECH, INC · Lu-177 targeted to tumor vasculature
PC Preclinical
Roche · Cobimetinib
P2 Phase 2
Roche · Ipatasertib
P3+ Phase 3+
(Active)
Merck & Co. · Tivantinib
P2 Phase 2
Novartis · Sonidegib
P1 Phase 1
Daiichi Sankyo · Pexidartinib
P2 Phase 2
DIM
P2 Phase 2
Novartis · LCL161
P2 Phase 2
Eisai · E7449
P2 Phase 2
Merck & Co. · Dinaciclib
P1 Phase 1
Novartis · Alpelisib
P3+ Phase 3+
Gilead Sciences · Sacituzumab govitecan
AP Approved
(Active)
CASI Pharmaceuticals · ENMD-2076
P2 Phase 2
Synta Pharmaceuticals (Madrigal) · Ganetespib
P2 Phase 2
AstraZeneca · Durvalumab
P3+ Phase 3+
(Active)
Eli Lilly · Crenigacestat
P1 Phase 1
Vorinostat
P1 Phase 1
AEterna Zentaris · Zoptarelin doxorubicin
P2 Phase 2
Gefitinib
P2 Phase 2
Exelixis · Cabozantinib
P2 Phase 2
(Active)
AVEO Oncology · Tivozanib
P2 Phase 2
Gilead Sciences · TROP-2-targeted tetrameric ranpirnase
PC Preclinical
Ipsen · Irinotecan liposome
P1 Phase 1
Cabazitaxel
P2 Phase 2
Spexis (Polyphor) · Balixafortide
P1 Phase 1
University of Pennsylvania
P1 Phase 1
FOR-ROBIN
PC Preclinical
DHA
P2 Phase 2
Pfizer · Nirogacestat
P2 Phase 2
AstraZeneca · AZD8186
P1 Phase 1
AstraZeneca · Vistusertib
P2 Phase 2
(Active)
Pfizer · Enzalutamide
P3+ Phase 3+
(Active)
Roche · Atezolizumab
AP Approved
(Active)
Roche · Pictilisib
P2 Phase 2
Celcuity · Gedatolisib
P2 Phase 2
(Active)
Pfizer · Dacomitinib
P1 Phase 1
EPIGEN BIOSCIENCES, INC
PC Preclinical
METACLIPSE THERAPEUTICS CORPORATION
PC Preclinical
Debiopharm · Xevinapant
P1 Phase 1
Bristol Myers Squibb · Ipilimumab
P2 Phase 2
(Active)
Nimotuzumab
P2 Phase 2
Novartis · Vintafolide
P2 Phase 2
Pfizer · Ladiratuzumab vedotin
P2 Phase 2
AstraZeneca · Tremelimumab
P2 Phase 2
(Active)
Lytix Biopharma · LTX-315
P1 Phase 1
Takeda · Orteronel
P2 Phase 2
Celldex Therapeutics · Glembatumumab vedotin
P2 Phase 2
Ocuphire Pharma · Supinoxin
P2 Phase 2
Corcept Therapeutics · Mifepristone
P2 Phase 2
(Active)
Baylor Research Institute · Dendritic cell vaccine
P2 Phase 2
KADMON CORPORATION
PC Preclinical
NANOMETICS · MTDIA
PC Preclinical
PROVID PHARMACEUTICALS, INC · TIC10
PC Preclinical
VISIONARY PHARMACEUTICALS, INC
PC Preclinical
Ribociclib
P2 Phase 2
(Active)
Jazz Pharmaceuticals · Dordaviprone
P2 Phase 2
Ruxolitinib
P2 Phase 2
(Active)
Curadis · CR1447
P2 Phase 2
Calithera Biosciences · Telaglenastat
P2 Phase 2
Pfizer · PF-06647263
P1 Phase 1
Toremifene
P3+ Phase 3+
Innocrin Pharmaceuticals · Seviteronel
P2 Phase 2
(Active)
Merck KGaA · Berzosertib
P1 Phase 1
(Active)
Incyte · Epacadostat
P2 Phase 2
Puma Biotechnology · Alisertib
P2 Phase 2
pharmaand · Lucitanib
P2 Phase 2
Eli Lilly · Prexasertib
P2 Phase 2
AstraZeneca · Capivasertib
P3+ Phase 3+
(Active)
Merck KGaA · Avelumab
P3+ Phase 3+
(Active)
Pfizer · Cofetuzumab pelidotin
P1 Phase 1
Merck & Co. · Birabresib
P1 Phase 1
AstraZeneca · Ceralasertib
P2 Phase 2
(Active)
Curis · Fimepinostat
P1 Phase 1
Bristol Myers Squibb · Nivolumab
P2 Phase 2
(Active)
BioNTech · IVAC_W_bre1_uID / IVAC_M_uID
P1 Phase 1
Zoledronic acid
P3+ Phase 3+
(Active)
Washington University in St. Louis · Personalized neoantigen DNA vaccine
P1 Phase 1
(Active)
S-equol
P1 Phase 1
Icotinib
P2 Phase 2
AbbVie · Losatuxizumab vedotin
P1 Phase 1
Bayer · BAY 1187982
P1 Phase 1
GTx · Enobosarm
P2 Phase 2
Dompé Farmaceutici · Reparixin
P2 Phase 2
Novartis · PCA062
P1 Phase 1
Romidepsin
P2 Phase 2
(Active)
Selinexor
P2 Phase 2
(Active)
AbbVie · Ibrutinib
P2 Phase 2
JYANT, INC · PEG-wLPrA2
PC Preclinical
Washington University in St. Louis · Personalized synthetic long peptide vaccine
P2 Phase 2
(Active)
City of Hope · p53MVA
P1 Phase 1
(Active)
Novartis · Lacnotuzumab
P2 Phase 2
Fujifilm Toyama Chemical · FF-21101
P1 Phase 1
Roche · Taselisib
P2 Phase 2
Novartis · Ieramilimab
P2 Phase 2
Roche · Navoximod
P1 Phase 1
Otsuka Holdings · Onalespib
P1 Phase 1
AstraZeneca · Adavosertib
P2 Phase 2
Marker Therapeutics · TPIV200
P2 Phase 2
(Active)
Afatinib
P2 Phase 2
OncoSec Medical (Grand Decade) · Tavokinogene telseplasmid
P2 Phase 2
REVERIS THERAPEUTICS
PC Preclinical
Pfizer · Ivuxolimab
P2 Phase 2
(Active)
Pfizer · PD-0360324
P2 Phase 2
Pfizer · Utomilumab
P2 Phase 2
(Active)
Regeneron Pharmaceuticals · Vidutolimod
P2 Phase 2
(Active)
Sanofi · SAR428926
P1 Phase 1
Selumetinib
P2 Phase 2
Huaier
P3+ Phase 3+
(Active)
Pemetrexed
P2 Phase 2
Palbociclib
P2 Phase 2
(Active)
SillaJen · Pexa-Vec
P2 Phase 2
Esperas Pharma · LY2880070
P2 Phase 2
Infinity Pharmaceuticals · Eganelisib
P2 Phase 2
SCI-ENGI-MEDCO SOLUTIONS, INC · AAAPT
PC Preclinical
SIGNALRX PHARMACEUTICALS, INC
PC Preclinical
GSK · Niraparib
P3+ Phase 3+
(Active)
Eli Lilly · Galunisertib
P1 Phase 1
Denosumab
P2 Phase 2
Oncologie (Peregrine) · Bavituximab
IND IND
Fred Hutchinson Cancer Center · ROR1 CAR-T
P1 Phase 1
Takeda · Sapanisertib
P2 Phase 2
PIQUR Therapeutics (Torqur) · Bimiralisib
P2 Phase 2
Bristol Myers Squibb · BMS-986178
P2 Phase 2
UbiVac · DPV-001
P2 Phase 2
ADECTO PHARMACEUTICALS, INC
PC Preclinical
Corcept Therapeutics · Relacorilant
P2 Phase 2
Amgen · Talimogene laherparepvec
P2 Phase 2
GSK · Pemrametostat
P1 Phase 1
Memorial Sloan Kettering Cancer Center · Mesothelin CAR-T
P1 Phase 1
(Active)
BioLite · BLEX 404
P1 Phase 1
(Active)
OncoPep · PVX-410
P2 Phase 2
(Active)
University Hospital Basel
P2 Phase 2
Takeda · Mivavotinib
P1 Phase 1
The Methodist Hospital Research Institute · L-NMMA
P2 Phase 2
(Active)
Shanghai Junshi Biosciences · Toripalimab
P3+ Phase 3+
(Active)
OREGA Biotech
PC Preclinical
STEMSYNERGY THERAPEUTICS, INC
PC Preclinical
Novartis · QBM076
P1 Phase 1
Novartis · Siremadlin
P1 Phase 1
Novartis · Canakinumab
P1 Phase 1
Novartis · CJM112
P1 Phase 1
Novartis · Nazartinib
P1 Phase 1
OncoTherapy Science · OTS167
P1 Phase 1
(Active)
Novartis · FAZ053
P1 Phase 1
University of Arkansas · P10s-PADRE
P2 Phase 2
Placon Therapeutics · BTP-114
P1 Phase 1
Boehringer Ingelheim · Ezabenlimab
P1 Phase 1
G1 Therapeutics · Trilaciclib
P3+ Phase 3+
HiberCell · Odetiglucan
P2 Phase 2
Nektar Therapeutics · Bempegaldesleukin
P2 Phase 2
Sanofi · SAR566658
P2 Phase 2
Ixazomib
P2 Phase 2
Mirvetuximab
P2 Phase 2
AbbVie · Budigalimab
P1 Phase 1
(Active)
Houston Methodist · ADV/HSV-tk
P2 Phase 2
DUALOGICS
PC Preclinical
SYNERGYS BIOTHERAPEUTICS, INC · Anti-EGFR-huEndo-P125A
PC Preclinical
VLP THERAPEUTICS, INC
PC Preclinical
Merck & Co. · Ulevostinag
P1 Phase 1
AbbVie · ABBV-368
P1 Phase 1
(Active)
Jiangsu Hengrui Pharmaceuticals · Fuzuloparib
P3+ Phase 3+
(Active)
Eli Lilly · LY3295668
P2 Phase 2
Formation Biologics · AVID100
P2 Phase 2
Eli Lilly · LY3143921
P1 Phase 1
KIROMIC, INC
PC Preclinical
Imipramine
P1 Phase 1
Abemaciclib
P2 Phase 2
(Active)
BeOne Medicines · Pamiparib
P2 Phase 2
ImmunityBio · ETBX-011/-051/-061 and
P2 Phase 2
ImmunityBio · Nogapendekin alfa inbakicept
P2 Phase 2
ImmunityBio · PD-L1 t-haNK
P2 Phase 2
BerGenBio · Bemcentinib
P2 Phase 2
Takeda · Serabelisib
P2 Phase 2
Novartis · Taminadenant
P2 Phase 2
MacroGenics · Tebotelimab
P1 Phase 1
Epalrestat
P2 Phase 2
HUTCHMED · Fruquintinib
P1 Phase 1
Cantargia · Nadunolimab
P2 Phase 2
VIOMEDIX
PC Preclinical
NEULINK, INC
PC Preclinical
Roche · Autogene cevumeran
P1 Phase 1
MD Anderson Cancer Center · IACS-010759
P1 Phase 1
Roche · RO6870810
P1 Phase 1
IBC Pharmaceuticals · E1-3
PC Preclinical
AbbVie · SC-005
P1 Phase 1
Effector Therapeutics · Tomivosertib
P2 Phase 2
Boston Pharmaceuticals · BOS172722
P1 Phase 1
Bristol Myers Squibb · CC-671
PC Preclinical
Eli Lilly · LY3300054
P1 Phase 1
Eli Lilly · LY3381916
P1 Phase 1
Mundipharma · Tinostamustine
P2 Phase 2
Biosplice Therapeutics · Cirtuvivint
P1 Phase 1
Atorvastatin
P2 Phase 2
Carrick Therapeutics · Samuraciclib
P2 Phase 2
Bristol Myers Squibb · BMS-986249
P2 Phase 2
Darolutamide
P2 Phase 2
(Active)
ImmunityBio · Aldoxorubicin
P2 Phase 2
NIROGYONE THERAPEUTICS
PC Preclinical
(Active)
ONCOTHERAPY SOLUTIONS · OTS-P22
PC Preclinical
(Active)
PARKSIDE SCIENTIFIC, INC
PC Preclinical
HRYZ Biotech · MASCT-I
P1 Phase 1
Jiangsu Hengrui Pharmaceuticals · Camrelizumab
P3+ Phase 3+
(Active)
Merck & Co. · Boserolimab
P2 Phase 2
AstraZeneca · Datopotamab deruxtecan
AP Approved
(Active)
Servier · S81694
P2 Phase 2
Iovance Biotherapeutics · LN-145
P2 Phase 2
(Active)
Corvus Pharmaceuticals · Ciforadenant
P1 Phase 1
Corvus Pharmaceuticals · Mupadolimab
P1 Phase 1
BioAtla · Ozuriftamab vedotin
P2 Phase 2
Xencor · Vudalimab
P1 Phase 1
Pfizer · Ebvaciclib
P2 Phase 2
OBI Pharma · Adagloxad simolenin
P3+ Phase 3+
(Active)
Eisai · Lenvatinib
P2 Phase 2
(Active)
Merck & Co. · MK-4830
P1 Phase 1
Genmab · HexaBody-DR5/DR5
P2 Phase 2
Merck KGaA · Bintrafusp alfa
P2 Phase 2
AIM ImmunoTech · Rintatolimod
P2 Phase 2
Celecoxib
P2 Phase 2
(Active)
Deciphera Pharmaceuticals · Rebastinib
P2 Phase 2
Interferon alfa-2b
P2 Phase 2
AGILVAX, INC · AX09
PC Preclinical
AstraZeneca · Oleclumab
P2 Phase 2
(Active)
Crizotinib
P2 Phase 2
(Active)
ADC Therapeutics · Camidanlumab tesirine
P1 Phase 1
CELDARA MEDICAL · CADD522
PC Preclinical
Treadwell Therapeutics · Ocifisertib
P2 Phase 2
(Active)
Immune System Key · Nerofe
P2 Phase 2
TransThera Sciences · Tinengotinib
P2 Phase 2
NUPEAK THERAPEUTICS, INC
PC Preclinical
Compugen · COM701
P1 Phase 1
Jina Pharmaceuticals · Nanosomal docetaxel lipid suspension
P3+ Phase 3+
(Active)
ERYtech Pharma (Pherecydes) · Eryaspase
P3+ Phase 3+
Pfizer · PF-06936308
P1 Phase 1
VEANA THERAPEUTICS · alpha-TEA
PC Preclinical
GSK · GSK3145095
P1 Phase 1
Immatics · Anzutresgene autoleucel
P2 Phase 2
(Active)
Sinocelltech · SCT200
P2 Phase 2
Leflunomide
P2 Phase 2
(Active)
Arcus Biosciences · Etrumadenant
P1 Phase 1
PharmAbcine · Olinvacimab
P2 Phase 2
MacroGenics · Vobramitamab duocarmazine
P2 Phase 2
Moderna · mRNA-2752
P1 Phase 1
AstraZeneca · Trastuzumab deruxtecan
AP Approved
(Active)
Novartis · Capmatinib
P1 Phase 1
AstraZeneca · FPI-1434 / FPI-1175
P1 Phase 1
I-Mab / TJ Biopharma · Efineptakin alfa
P2 Phase 2
SELLAS Life Sciences · Galinpepimut-S
P2 Phase 2
Evelo Biosciences · EDP1503
P1 Phase 1
BOUND THERAPEUTICS · microRNA-21 blockade
PC Preclinical
IRIA PHARMA
PC Preclinical
MODULATION THERAPEUTICS, INC · MTI-301
PC Preclinical
(Active)
Phoenix Molecular Designs · PMD-026
P1 Phase 1
(Active)
Aspirin
P2 Phase 2
Pyrotinib
P2 Phase 2
(Active)
Sanofi · Alomfilimab
P2 Phase 2
Tempest Therapeutics · TPST-1120
P1 Phase 1
CytoDyn · Leronlimab
P2 Phase 2
(Active)
Sino Biopharmaceutical · Anlotinib
P3+ Phase 3+
(Active)
Sino Biopharmaceutical · Benmelstobart
P3+ Phase 3+
(Active)
Leap Therapeutics · TRX518
P1 Phase 1
Jiangsu Alphamab · KN046
P2 Phase 2
iTeos Therapeutics · Inupadenant
P1 Phase 1
AbbVie · ABBV-927
P1 Phase 1
(Active)
Zenith Epigenetics · ZEN-3694
P2 Phase 2
(Active)
Birdie Biopharmaceuticals · BDB001
P2 Phase 2
(Active)
Merck & Co. · MK-0482
P1 Phase 1
Odonate Therapeutics · Tesetaxel
P2 Phase 2
Spirita Oncology · E6201
PC Preclinical
Cyteir Therapeutics · CYT-0851
P2 Phase 2
Minerva Biotechnologies · huMNC2-CAR22 / CAR44
P1 Phase 1
(Active)
Gilead Sciences · CART-TnMUC1
P1 Phase 1
NuGenerex Immuno-Oncology · AE37
P2 Phase 2
Otsuka Holdings · Futibatinib
P2 Phase 2
Eli Lilly · Samotolisib
P2 Phase 2
Evestra · EC359
PC Preclinical
(Active)
ASCLEPIX THERAPEUTICS, INC · AXT201
PC Preclinical
Oncolytics Biotech · Pelareorep
P2 Phase 2
(Active)
Universidad Nacional de Colombia
P1 Phase 1
(Active)
CytoMed Therapeutics
P1 Phase 1
Bristol Myers Squibb · Sitravatinib
P2 Phase 2
(Active)
Jiangsu Hengrui Pharmaceuticals · Famitinib
P3+ Phase 3+
(Active)
ASTX727
P1 Phase 1
(Active)
Mayo Clinic · RBX7455
P1 Phase 1
OncoC4 · Gotistobart
P2 Phase 2
(Active)
UNC Lineberger Comprehensive Cancer Center · Parsaclisib
P1 Phase 1
Trifluridine-tipiracil
P2 Phase 2
Merck & Co. · Sacituzumab tirumotecan
AP Approved
(Active)
Roche · RO7296682
P1 Phase 1
Bicycle Therapeutics · BT5528
P2 Phase 2
(Active)
Innova Therapeutics · IVT-8086
PC Preclinical
(Active)
Tucidinostat
P2 Phase 2
(Active)
ACOMHAL RESEARCH, INC
PC Preclinical
(Active)
CYTONUS THERAPEUTICS, INC · CA-IL-12
PC Preclinical
(Active)
ENZYME BY DESIGN, INC
PC Preclinical
(Active)
RECOMBINATION THERAPEUTICS
PC Preclinical
(Active)
Astellas Pharma · Enfortumab vedotin
P2 Phase 2
(Active)
Atreca · ATRC-101
P1 Phase 1
Regeneron Pharmaceuticals · Cemiplimab
P2 Phase 2
(Active)
Veru · Sabizabulin
IND IND
Regeneron Pharmaceuticals · Fianlimab
P2 Phase 2
(Active)
Bortezomib
P1 Phase 1
(Active)
Volastra Therapeutics · AMG 650
P1 Phase 1
Bavarian Nordic · Brachyury-TRICOM
P1 Phase 1
Eisai · Farletuzumab ecteribulin
P2 Phase 2
(Active)
Shanghai Henlius Biotech · Serplulimab
P3+ Phase 3+
(Active)
Jiangsu Hengrui Pharmaceuticals · Adebrelimab
P3+ Phase 3+
(Active)
Belinostat
P1 Phase 1
Amgen · Cabiralizumab
P1 Phase 1
Copanlisib
P2 Phase 2
(Active)
Roswell Park
P2 Phase 2
(Active)
Brooklyn ImmunoTherapeutics · IRX-2
P2 Phase 2
(Active)
Genmab · GEN1044
P2 Phase 2
Adlai Nortye · AN0025
P1 Phase 1
(Active)
Incyte · Retifanlimab
P2 Phase 2
(Active)
Etoposide
P2 Phase 2
Ayala Pharmaceuticals · AL101
P2 Phase 2
Tizona Therapeutics · TTX-080
P1 Phase 1
(Active)
BeOne Medicines · Tislelizumab
P3+ Phase 3+
(Active)
AstraZeneca · AZD8701
P1 Phase 1
Merck & Co. · Zilovertamab vedotin
P2 Phase 2
Merck & Co. · Gebasaxturev
P1 Phase 1
AntiCancer · o-rMETase
PC Preclinical
(Active)
Fate Therapeutics · FT516 / FT538
P1 Phase 1
IASO THERAPEUTICS, INC
PC Preclinical
Bicycle Therapeutics · Zelenectide pevedotin
P2 Phase 2
(Active)
Roche · Tiragolumab
P2 Phase 2
(Active)
Codiak BioSciences · exoSTING
P2 Phase 2
CytomX Therapeutics · CX-2009
P2 Phase 2
CytomX Therapeutics · Pacmilimab
P2 Phase 2
CytoVac · ALECSAT
P1 Phase 1
Sun Pharmaceutical Industries
PC Preclinical
AbbVie · IMGC936
P2 Phase 2
Fred Hutchinson Cancer Center · MAGE-A1 TCR-T
P2 Phase 2
Bexarotene
P1 Phase 1
(Active)
Concentra Biosciences · JTX-8064
P2 Phase 2
Concentra Biosciences · Pimivalimab
P2 Phase 2
Anixa Biosciences
P1 Phase 1
(Active)
Vitamin D3
P2 Phase 2
(Active)
Oncopharmatech · OPT-0010 / OPT-0139
PC Preclinical
ARREVUS, INC
PC Preclinical
(Active)
Merck & Co. · Patritumab deruxtecan
P2 Phase 2
(Active)
Theratechnologies · Sudocetaxel zendusortide
P1 Phase 1
(Active)
Kronos Bio · KB-0742
P2 Phase 2
Moxifloxacin
P3+ Phase 3+
(Active)
Sintilimab
P2 Phase 2
(Active)
Transgene · BT-001
P2 Phase 2
Exelixis · XL102
P1 Phase 1
Taizhou Hanzhong Biopharmaceuticals · Pucotenlimab
P2 Phase 2
Simcha Therapeutics · ST-067
P2 Phase 2
(Active)
Inavolisib
P2 Phase 2
(Active)
Takeda · Dazostinag
P1 Phase 1
BioNTech · Pumitamig
P3+ Phase 3+
(Active)
Innovent Biologics · IBI323
P1 Phase 1
Exelixis · XB002
P1 Phase 1
LASSOGEN, INC
PC Preclinical
Convert Pharmaceuticals · CP-506
P2 Phase 2
(Active)
Gilead Sciences · Magrolimab
P2 Phase 2
SUNHO (China) BioPharmaceutical · IBC0966
P2 Phase 2
(Active)
AbbVie · Telisotuzumab adizutecan
P1 Phase 1
(Active)
QUADRIGA BIOSCIENCES, INC · QBS10072S
PC Preclinical
(Active)
Hummingbird Bioscience · HMBD-001
P2 Phase 2
(Active)
CSPC Pharmaceutical · SG001
P2 Phase 2
Akeso · AK131
P2 Phase 2
(Active)
Choline
P2 Phase 2
(Active)
Cromolyn
P2 Phase 2
(Active)
Efavirenz
P2 Phase 2
(Active)
Jiangsu Hengrui Pharmaceuticals · SHR-A2102
P2 Phase 2
(Active)
Jiangsu Hengrui Pharmaceuticals · Trastuzumab rezetecan
P3+ Phase 3+
(Active)
Memgen · MEM-288
P1 Phase 1
(Active)
Theophylline
P2 Phase 2
(Active)
Imugene · CF33-hNIS-antiPDL1
P1 Phase 1
(Active)
Otsuka Holdings · Tolinapant
P1 Phase 1
(Active)
Hummingbird Bioscience · HMBD-002
P1 Phase 1
SynerGene Therapeutics · SGT-53
P1 Phase 1
Losartan
P2 Phase 2
X4 Pharmaceuticals · Mavorixafor
P2 Phase 2
Nurix Therapeutics · NX-1607
P1 Phase 1
(Active)
PharmaMar · Lurbinectedin
P2 Phase 2
Temozolomide
P2 Phase 2
(Active)
MBQ Pharma · MBQ-167
P1 Phase 1
(Active)
Orinove · ORIN1001
P2 Phase 2
(Active)
BioPhoenix · Up284
PC Preclinical
(Active)
CULNEXIN THERAPEUTICS, INC
PC Preclinical
(Active)
DNATWO, INC
PC Preclinical
(Active)
ISOPRENE PHARMACEUTICALS, INC · VNLG-152R
PC Preclinical
(Active)
SENEX BIOTECHNOLOGY, INC
PC Preclinical
(Active)
TRIO PHARMACEUTICALS INC · TIE-ADC
PC Preclinical
(Active)
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical · FDA018
P3+ Phase 3+
(Active)
Pfizer · Felmetatug vedotin
P1 Phase 1
Icosapent ethyl
P2 Phase 2
Rubius Therapeutics · RTX-224
P2 Phase 2
Akeso · Ligufalimab
P2 Phase 2
(Active)
Summit Therapeutics · Ivonescimab
P3+ Phase 3+
(Active)
Incyte · INCB123667
P1 Phase 1
(Active)
Penpulimab
P2 Phase 2
(Active)
Nuvation Bio · NUV-868
P1 Phase 1
Dantari · DAN-222
P2 Phase 2
(Active)
Mayo Clinic · Neoantigen peptide vaccine
P2 Phase 2
(Active)
Teon Therapeutics · TT-702
P2 Phase 2
(Active)
Deferoxamine
P2 Phase 2
Agenus · Balstilimab
P3+ Phase 3+
(Active)
Ivermectin
P2 Phase 2
(Active)
Amgen · Bemarituzumab
P2 Phase 2
Scancell · Modi-1
P2 Phase 2
(Active)
Shenzhen Chipscreen Biosciences · Chiauranib
P2 Phase 2
Sichuan Baili Pharmaceutical (SystImmune) · BL-M02D1
P1 Phase 1
(Active)
Second Affiliated Hospital of Guangzhou Medical University
P1 Phase 1
(Active)
AbbVie · Navitoclax
P1 Phase 1
(Active)
Zentalis Pharmaceuticals · Azenosertib
P1 Phase 1
Day One Biopharmaceuticals · Emiltatug ledadotin
P2 Phase 2
(Active)
Cardiff Oncology · Onvansertib
P2 Phase 2
(Active)
Cytovation · CyPep-1
P2 Phase 2
Laekna Therapeutics · Afuresertib
P1 Phase 1
Laekna Therapeutics · LAE005
P1 Phase 1
Pharosgen
PC Preclinical
(Active)
Light Chain Bioscience (Novimmune) · NI-1801
P1 Phase 1
(Active)
BioNTech · DB-1305 / BNT325
P2 Phase 2
(Active)
Fundació Clínic Barcelona · NUMARZU-001
P2 Phase 2
(Active)
OncXerna Therapeutics · Navicixizumab
P2 Phase 2
(Active)
University of Washington · STEMVAC
P2 Phase 2
(Active)
Madera Therapeutics · TR-107
PC Preclinical
(Active)
Jacobio Pharmaceuticals · JAB-2485
P2 Phase 2
(Active)
Adagene · ADG106
P2 Phase 2
(Active)
Syndax Pharmaceuticals · Axatilimab
P2 Phase 2
(Active)
Phost'In Therapeutics · PhOx430
P1 Phase 1
(Active)
H. Lee Moffitt Cancer Center and Research Institute · Dendritic cell vaccines
P2 Phase 2
(Active)
Bayer · BAY 3375968
P1 Phase 1
(Active)
STINGRAY THERAPEUTICS, INC · SR-8541A
P1 Phase 1
(Active)
Novartis · KFA115
P1 Phase 1
Simvastatin
P2 Phase 2
(Active)
Shanghai Jiaolian Drug R&D · B013
P3+ Phase 3+
Hinova Pharmaceuticals · HC-1119
PC Preclinical
(Active)
SynDevRx · Evexomostat
P2 Phase 2
(Active)
Turnstone Biologics · TBio-4101
P1 Phase 1
Genmab · Rinatabart sesutecan
P2 Phase 2
(Active)
Innovent Biologics · IBI354
P2 Phase 2
(Active)
Jiangsu Alphamab · JSKN003
P2 Phase 2
(Active)
Jiangsu Hengrui Pharmaceuticals · SHR-A1921
P2 Phase 2
(Active)
Mabwell (Shanghai) Bioscience · Bulumtatug fuvedotin
P3+ Phase 3+
(Active)
Shanghai Junshi Biosciences · JS207
P2 Phase 2
(Active)
Sino Biopharmaceutical · TQB2102
P2 Phase 2
(Active)
Sino Biopharmaceutical · TQB2868
P2 Phase 2
(Active)
Xencor · XmAb808
P1 Phase 1
AmunBio · AMUN-003
PC Preclinical
(Active)
A&G Pharmaceutical · AG-01
P1 Phase 1
(Active)
Arcus Biosciences · Zimberelimab
P2 Phase 2
(Active)
CADRE BIOSCIENCE
PC Preclinical
(Active)
CREEGH PHARMACEUTICALS, INC · CP-8
PC Preclinical
(Active)
MOLECULAR THERANOSTICS
PC Preclinical
(Active)
WINDOW THERAPEUTICS, INC
PC Preclinical
(Active)
Henan Ruida Bio-Tech Medicine
PC Preclinical
(Active)
Quercetin
P2 Phase 2
(Active)
Xilio Therapeutics · XTX301
P2 Phase 2
(Active)
First Affiliated Hospital · SZ011
P1 Phase 1
Lumara Bio Oncologics · DPI-4452
P2 Phase 2
(Active)
Pyxis Oncology · PYX-201
P1 Phase 1
(Active)
Imatinib
P2 Phase 2
(Active)
Propranolol
P2 Phase 2
(Active)
Surufatinib
P2 Phase 2
University of Illinois Chicago · GR2-128
PC Preclinical
(Active)
Flow Pharma
PC Preclinical
(Active)
SillaJen · BAL0891
P1 Phase 1
(Active)
BeOne Medicines · Ociperlimab
P2 Phase 2
Menarini · MEN1611
P2 Phase 2
(Active)
Aldesleukin
P2 Phase 2
(Active)
Boundless Bio · BBI-355
P1 Phase 1
InxMed · Ifebemtinib
P2 Phase 2
SYMPHONY BIOSCIENCES, INC
PC Preclinical
(Active)
Tocilizumab
P2 Phase 2
(Active)
Roche · Tobemstomig
P2 Phase 2
Cellectis
PC Preclinical
(Active)
ALX Oncology · Evorpacept
P2 Phase 2
(Active)
TransCode Therapeutics · TTX-MC138
P2 Phase 2
(Active)
Bristol Myers Squibb · BMS-986449
P2 Phase 2
(Active)
LOXIGEN, INC
PC Preclinical
(Active)
Pfizer · PF-07224826
P1 Phase 1
Rezvilutamide
P2 Phase 2
Lantern Pharma · LP-184
P2 Phase 2
(Active)
Ministry of Health, Saudi Arabia · Glucosodiene
P1 Phase 1
Beijing Biostar Pharmaceuticals · Utidelone
P3+ Phase 3+
(Active)
Bristol Myers Squibb · Izalontamab brengitecan
P3+ Phase 3+
(Active)
University of Southern California · NY-ESO-1 TCR-T
P1 Phase 1
(Active)
Pfizer · Disitamab vedotin
P2 Phase 2
(Active)
Adcentrx Therapeutics · ADRX-0706
P1 Phase 1
(Active)
Bolt Biotherapeutics · BDC-3042
P1 Phase 1
Replimune · Vusolimogene oderparepvec
P2 Phase 2
Convalife (Shanghai) · CVL218
P2 Phase 2
(Active)
Boehringer Ingelheim · Brigimadlin
P2 Phase 2
Dartmouth-Hitchcock Medical Center · Tetrathiomolybdate
P2 Phase 2
(Active)
Compass Therapeutics · CTX-8371
P1 Phase 1
(Active)
Xiaopi
P2 Phase 2
Xenothera · XON7
P2 Phase 2
(Active)
ProLynx · PLX038
P2 Phase 2
Gilead Sciences · GS-0201
P1 Phase 1
(Active)
Genmab · GEN1107
P2 Phase 2
Biocytogen · BCG033
PC Preclinical
(Active)
JW Pharmaceutical · JW2286
P1 Phase 1
(Active)
SAPIENCE THERAPEUTICS, INC · ST316
PC Preclinical
(Active)
VONA ONCOLOGY · VDX-431
IND IND
(Active)
Rhizen Pharmaceuticals · Tenalisib
P2 Phase 2
(Active)
Cadonilimab
P2 Phase 2
(Active)
Nanjing Immunophage Biotech · IPG1094
P1 Phase 1
(Active)
Eli Lilly · LY4101174
P1 Phase 1
(Active)
Sutro Biopharma · Luveltamab tazevibulin
P2 Phase 2
Cyclosporin A
P1 Phase 1
Strand Therapeutics · STX-001
P2 Phase 2
(Active)
NiKang Therapeutics · NKT3447
P1 Phase 1
NiKang Therapeutics · NKT3964
P1 Phase 1
(Active)
Pure Biologics · PBA-0405
P1 Phase 1
(Active)
Agenus · Botensilimab
P3+ Phase 3+
(Active)
Merck KGaA · Tuvusertib
P1 Phase 1
Monopar Therapeutics · MNPR-101
P1 Phase 1
(Active)
UNC Lineberger Comprehensive Cancer Center · iC9-CAR.B7-H3 T cells
P1 Phase 1
(Active)
Inhibrx Biosciences · INBRX-106
P2 Phase 2
(Active)
Inosine
P2 Phase 2
(Active)
Intensity Therapeutics · INT230-6
P2 Phase 2
(Active)
ATRA
P2 Phase 2
(Active)
Sino Biopharmaceutical · LM-108
P2 Phase 2
(Active)
Eli Lilly · Sofetabart mipitecan
P1 Phase 1
(Active)
BioNTech · YL202
P2 Phase 2
(Active)
ProDa BioTech · ProAgio
P2 Phase 2
(Active)
Eli Lilly · LY4052031
P1 Phase 1
(Active)
Innovent Biologics · IBI363
P1 Phase 1
(Active)
Sumitomo Pharma · SMP-3124LP
P2 Phase 2
(Active)
Essen Biotech
P2 Phase 2
(Active)
Mirabegron
P2 Phase 2
(Active)
Epsilogen · MOv18 IgE
P1 Phase 1
(Active)
Exelixis · XB010
P1 Phase 1
(Active)
Novartis · NNS309
P1 Phase 1
(Active)
Processa Pharmaceuticals · PCS6422
P2 Phase 2
Circle Pharma · CID-078
P1 Phase 1
(Active)
Kolon Pharmaceuticals · AON-MB23
PC Preclinical
(Active)
JenKem Technology · JK-1201I
P2 Phase 2
(Active)
Debiopharm · Debio 0123
P2 Phase 2
(Active)
NEC Bio · NECVAX-NEO1
P2 Phase 2
(Active)
Levocetirizine
P2 Phase 2
(Active)
Dupilumab
P1 Phase 1
(Active)
RemeGen · RC148
P2 Phase 2
(Active)
Jiangsu Hengrui Pharmaceuticals · SHR-A2009
P2 Phase 2
(Active)
Arsenic trioxide
P2 Phase 2
(Active)
A2 Biotherapeutics · A2B395
P2 Phase 2
(Active)
BeBetter Med · BEBT-209
P3+ Phase 3+
(Active)
Pure Biologics · PBA-0111
P1 Phase 1
(Active)
Anakinra
P2 Phase 2
Reistone Biopharma · Ivarmacitinib
P2 Phase 2
(Active)
Shanghai Escugen Biotechnology · ESG401
P3+ Phase 3+
(Active)
ImmuneOnco Biopharmaceuticals · IMM2510
P2 Phase 2
(Active)
IMMUNOVA THERAPEUTICS · IMT-422
PC Preclinical
(Active)
Repertoire Immune Medicines · RPTR-1.201
P1 Phase 1
(Active)
WEATHERWAX BIOTECHNOLOGIES CORPORATION
PC Preclinical
(Active)
Biolosion probiotic
P2 Phase 2
(Active)
GSK · HS-20093
P1 Phase 1
(Active)
GSK · Mo-Rez
P2 Phase 2
(Active)
Jiangsu Hansoh Pharmaceutical · HS-10502
P1 Phase 1
(Active)
Qilu Pharmaceutical · Iparomlimab and tuvonralimab
P3+ Phase 3+
(Active)
PROMILEAD
PC Preclinical
(Active)
Marengo Therapeutics · Invikafusp alfa
P2 Phase 2
(Active)
Mainline Biosciences · MB0151
P2 Phase 2
(Active)
Calibr (Scripps) · ABBV-461 / CLBR001
P1 Phase 1
Mistletoe
P2 Phase 2
(Active)
Relatlimab
P2 Phase 2
(Active)
Naxitamab
P2 Phase 2
(Active)
Tianjin ConjuStar Biologics · SC-101
P2 Phase 2
(Active)
Shanghai Junshi Biosciences · Tifcemalimab
P2 Phase 2
(Active)
Biocad · BCD-236
P2 Phase 2
(Active)
Arcus Biosciences · Domvanalimab
P2 Phase 2
Senhwa Biosciences · Pidnarulex
P1 Phase 1
(Active)
Beijing Bio-Targeting Therapeutics · BioTTT001
P1 Phase 1
Pirfenidone
P2 Phase 2
(Active)
INTRA THERAPEUTICS
PC Preclinical
(Active)
PEARL SCIENTIFIC
PC Preclinical
(Active)
SEAK THERAPEUTICS · SEAK193
PC Preclinical
(Active)
ProteinQure · PQ203
P1 Phase 1
(Active)
Shenzhen Majory Biotech · MR001
P2 Phase 2
(Active)
Changchun GeneScience Pharmaceuticals · GenSci140
P1 Phase 1
(Active)
Novartis · DFC413
P1 Phase 1
(Active)
Nanjing Leads Biolabs · LBL-024
P2 Phase 2
(Active)
FMT
P2 Phase 2
(Active)
Canadian Cancer Trials Group · GCAR1
P1 Phase 1
(Active)
Asher Biotherapeutics · AB248
P1 Phase 1
(Active)
Adze Biotechnology · ADZE1.C
PC Preclinical
(Active)
DAUNTLESS BIOTHERAPEUTICS, INC
PC Preclinical
(Active)
DuChem Bio · TROP-2-targeted theranostic
PC Preclinical
(Active)
NATSAR PHARMACEUTICALS, INC · RK-33
PC Preclinical
(Active)
TOOMER THERAPEUTICS, INC
PC Preclinical
(Active)
Onchilles Pharma · N17350
P2 Phase 2
(Active)
Xiaorong Sun · 225Ac-TR2205
P1 Phase 1
(Active)
Huabo Biopharm · HB0025
P2 Phase 2
(Active)
Zenyaku Kogyo · ZSTK3744
PC Preclinical
(Active)
Boundless Bio · BBI-940
P1 Phase 1
Biocity Biopharmaceutics · BC3195
P2 Phase 2
(Active)
Risedronate
P2 Phase 2
(Active)
Beijing Biotech
P2 Phase 2
(Active)
Shanghai Henlius Biotech · HLX43
P2 Phase 2
(Active)
IDEAYA Biosciences · IDE034
P1 Phase 1
(Active)
Qilu Pharmaceutical · QLC5513
P2 Phase 2
(Active)
Singlomics Biopharmaceuticals · DXP-106
P1 Phase 1
(Active)
Jiangsu Alphamab · JSKN016
P3+ Phase 3+
(Active)
Cedars-Sinai Medical Center · MO-03
P2 Phase 2
(Active)
Telomir Pharmaceuticals · Telomir-Zn
P2 Phase 2
(Active)
ImmuneOncia Therapeutics · IMC-002
P1 Phase 1
(Active)
Thena Biotech · THE-0504
P1 Phase 1
(Active)
Immunomic Therapeutics · ITI-5000
P1 Phase 1
(Active)
University Health Network, Toronto · Isunakinra
P2 Phase 2
(Active)
SURGE Therapeutics · SRG-514
P3+ Phase 3+
(Active)
CoRegen · CRG-150
P2 Phase 2
(Active)
ADT Pharmaceuticals · ADT-030
PC Preclinical
(Active)
Eddingpharm (Genor Biopharma) · GB268
P2 Phase 2
(Active)
Iovance Biotherapeutics · IOV-5001
P2 Phase 2
(Active)
Jiangsu Hengrui Pharmaceuticals · Retlirafusp alfa
P2 Phase 2
(Active)
BreakBio · BreakVax
P2 Phase 2
(Active)
Effector Therapeutics · Zotatifin
P1 Phase 1
(Active)
Qurient · Q901
P1 Phase 1
(Active)
AGONOX, INC · AGX-148
PC Preclinical
(Active)
Shanghai Junshi Biosciences · JS212
P2 Phase 2
(Active)
CSPC Pharmaceutical · SYS6043
P3+ Phase 3+
(Active)
Thymalfasin
P2 Phase 2
(Active)